Research - Page 142 of 720 Posts on Medivizor
Navigation Menu

Research Posts on Medivizor

Does pembrolizumab added to chemotherapy before surgery improve the outcomes of patients with early triple negative breast cancer?

Does pembrolizumab added to chemotherapy before surgery improve the outcomes of patients with early triple negative breast cancer?

Posted by on Jun 28, 2020 in Breast cancer | 0 comments

In a nutshell The study assessed whether pembrolizumab (Keytruda) could be used in addition to neoadjuvant chemotherapy (NAC; chemotherapy before surgery) to improve the outcomes of patients with early triple-negative breast cancer (TNBC). The study found that more patients treated with pembrolizumab had a complete response. Some...

Read More

Does olaparib increase survival in patients with metastatic castration-resistant prostate cancer?

Does olaparib increase survival in patients with metastatic castration-resistant prostate cancer?

Posted by on Jun 27, 2020 in Prostate cancer | 0 comments

In a nutshell This study assessed whether olaparib (Lynparza) affected progression-free survival (PFS; survival without cancer worsening) in patients with metastatic castration-resistant prostate cancer (mCRPC) and certain genetic mutations (abnormalities). The study found that olaparib improved PFS in these patients. Some...

Read More

Does genetic testing improve IVF outcomes?

Does genetic testing improve IVF outcomes?

Posted by on Jun 27, 2020 in Infertility | 0 comments

In a nutshell This study looked at the effect of preimplantation genetic testing (PGT) on in vitro fertilization (IVF) outcomes for women with a poor ovarian response (POR). It found that PGT led to similar birth rates, but there were fewer miscarriages. Some background The first step of the infertility treatment IVF is to stimulate and collect...

Read More

MTX-HOPE chemotherapy for patients over 70 with relapsed non-Hodgkin’s lymphoma

MTX-HOPE chemotherapy for patients over 70 with relapsed non-Hodgkin’s lymphoma

Posted by on Jun 27, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study looked at MTX-HOPE (methotrexate, hydrocortisone, vincristine, sobuzoxane, etoposide) to treat patients over 70 with non-Hodgkin’s lymphoma (NHL) which had returned after previous treatments. It found that MTX-HOPE was an effective and safe treatment for these patients. Some background NHL is a group of cancers of the...

Read More

Does an invasive approach benefit patients with stable coronary disease when compared to a conservative approach?

Does an invasive approach benefit patients with stable coronary disease when compared to a conservative approach?

Posted by on Jun 27, 2020 in Coronary artery disease | 0 comments

In a nutshell The study assessed whether an initial invasive strategy (IS) for treating stable coronary artery disease (CAD) in patients with moderate or severe ischemia (reduced blood supply to the heart) have a better outcome when compared to a conservative strategy (CS). The study concluded that over the course of 3.2 years, invasive...

Read More

How does ABVD chemotherapy affect the fertility of female patients with Hodgkin lymphoma?

How does ABVD chemotherapy affect the fertility of female patients with Hodgkin lymphoma?

Posted by on Jun 27, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study examined if ABVD chemotherapy impacted fertility in female patients with Hodgkin lymphoma (HL). The authors found that ABVD reduced the levels of one of the fertility hormones and the type of fertility treatment patients opted for was not affected by ABVD. Some background Many patients with HL are young and fertility...

Read More

How effective is S-1 maintenance chemotherapy for patients with advanced non-small cell lung cancer?

How effective is S-1 maintenance chemotherapy for patients with advanced non-small cell lung cancer?

Posted by on Jun 25, 2020 in Lung cancer | 0 comments

In a nutshell This study examined how effective S-1 (Teysuno) chemotherapy is for patients with advanced non-small cell lung cancer (NSCLC) following initial chemotherapy treatment. The results showed that S-1 improved patients’ survival without NSCLC worsening but increased the number of side effects. Some background Treatment for patients...

Read More

S1-based chemotherapy improves the outcomes of patients with advanced colorectal cancer

S1-based chemotherapy improves the outcomes of patients with advanced colorectal cancer

Posted by on Jun 25, 2020 in Colorectal cancer | 0 comments

In a nutshell This study compared the effectiveness and safety of two different chemotherapies in the treatment of advanced colorectal cancer (CRC). Researchers suggested that S1-based chemotherapy is a good option for the treatment of these patients. Some background CRC is one of the most common cancers worldwide. The standard treatment is surgery...

Read More

Evaluating the risk of secondary cancers after internal radiation therapy in patients with prostate cancer

Evaluating the risk of secondary cancers after internal radiation therapy in patients with prostate cancer

Posted by on Jun 25, 2020 in Prostate cancer | 0 comments

In a nutshell This study looked at the long-term risk of secondary cancers following brachytherapy (BT; internal radiation therapy) for prostate cancer. It found that treating prostate cancer with BT had a low risk of secondary cancers. Some background Prostate cancer is a slow-growing cancer of the prostate gland. Men with prostate cancer that has...

Read More

How safe and effective is biological therapy ranibizumab for patients with diabetic macular edema?

How safe and effective is biological therapy ranibizumab for patients with diabetic macular edema?

Posted by on Jun 23, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study examined the effectiveness and safety of biological therapy ranibizumab (Lucentis) for patients with diabetic macular edema (DME) that has never been treated. After one year, patients’ vision had improved significantly, particularly for patients who received 5 injections instead of 4. Some background Diabetic...

Read More